Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00802321 · ClinicalTrials.gov registry record · NA
Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects
A NA study of Alcoholism and Alcohol Abuse, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT00802321: Completed NA study of Alcoholism and Alcohol Abuse, sponsored by UConn Health.
NCT00802321 is a NA study of Alcoholism and Alcohol Abuse that has completed, run by UConn Health. The registered enrollment target is 40 participants, below the 374-participant average among 65 other Alcoholism trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00802321, a NA study of Alcoholism and Alcohol Abuse, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
To monitor the inhibition of 5a-reductase (5AR) enzyme activity at 1, 3, 7, 14, 21, 28 and 42 days following administration of a single dose of dutasteride (2, 3, or 4 mg) by measuring the change in blood levels of 3a-androstanediol glucuronide (3a-diolG) and the ratio of dihydrotestosterone (DHT) to testosterone. To accomplish this aim, an open-label, between-subjects dose comparison study design will be employed with subjects receiving a 2, 3, or 4 mg dosage. Subjects (up to n=40 enrolled to allow a minimum of 24 completers) will be randomly assigned to one of the 3 dose levels. Results of this study will inform the dose selection for a subsequent placebo-controlled, within-subject, crossover study of dutasteride on the effects of alcohol. A secondary aim of this study is to examine the correlation of a genetic variation in the type I 5AR gene and baseline DHT/T ratio and effect of dutasteride at day 3. A variation in this gene which is one of the targets of dutasteride has been reported to be associated with higher baseline levels of DHT.
Conditions Studied
Interventions
- DRUG Dutasteride
Study Locations (1)
Connecticut
- Unversity of Connecticut Health Center - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2006-04 |
| Est. Completion | 2006-11 |
| Phase | NA |
What the finished NCT00802321 record still lists
NCT00802321 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 374-participant average among 65 other Alcoholism trials with a reported enrollment target (89% lower).
The record links to 3 conditions, with Alcoholism appearing as the primary indexed condition, and to 1 intervention - of which Dutasteride is the first listed.
NCT00802321 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT00802321 about?
NCT00802321 is a clinical study titled "Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects". To monitor the inhibition of 5a-reductase (5AR) enzyme activity at 1, 3, 7, 14, 21, 28 and 42 days following administration of a single dose of dutasteride (2, 3, or 4 mg) by measuring the change in blood levels of 3a-androstanediol glucuronide (3a-diolG) and the ratio of dihydrotestosterone (DHT) t...
What is the current status of trial NCT00802321?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2006-04. Estimated completion is 2006-11.
What conditions does trial NCT00802321 study?
This clinical trial studies the following conditions: Alcoholism, Alcohol Abuse, Alcohol-Related Disorders.
What interventions are being tested in trial NCT00802321?
The interventions under investigation include: Dutasteride (DRUG).
Who is sponsoring clinical trial NCT00802321?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00802321 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcoholism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00802321's enrollment target sits among peer trials
40 54th of 65 higher than 9 of 65 other Alcoholism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcoholism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
RECRUITING · NA
-
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)
RECRUITING · NA
-
CRP and S&A for Inpatient Veterans
RECRUITING · NA
-
Behavioral and Functional Task Development, Implementation, and Testing
RECRUITING · NA
-
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
RECRUITING · NA
-
Alcohol and the Social Brain: An Alcohol-Administration Hyperscanning Study Employing a Within-Subject Design
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia